Beijing Health Guard Biotechnology920575.BJValuation Analysis

As of Oct 19, 2026, Beijing Health Guard Biotechnology (920575.BJ) trades at a negative P/E (-3.30x, due to a recent net loss), P/B of Negative, P/S of 4680.50x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/S sits at the 65th percentile over the trailing 10Y window (vs. 60th percentile over 3Y).
Cross-sectional valuation: P/B percentile data for Beijing Health Guard Biotechnology is still accumulating, both within its industry and across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Beijing Health Guard Biotechnology operates in the — sector. Data refreshes weekly and is for reference only, not investment advice.